+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Generalized Pustular Psoriasis (GPP) - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Generalized Pustular Psoriasis (GPP) - Global Clinical Trials Review, 2024

  • Clinical Trials
  • August 2024
  • 70 Pages
  • Global
From
Migraine: 68-Market Analysis and Sales Forecast - Product Thumbnail Image

Migraine: 68-Market Analysis and Sales Forecast

  • Report
  • August 2024
  • 18 Pages
  • Global
From
Migraine: Seven-Market Drug Forecast and Market Analysis - Product Thumbnail Image

Migraine: Seven-Market Drug Forecast and Market Analysis

  • Report
  • August 2024
  • 121 Pages
  • Global
From
Vitreo Retinal Surgery Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update - Product Thumbnail Image

Vitreo Retinal Surgery Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

  • Report
  • July 2024
  • 69 Pages
  • Global
From
Osteoporosis: Seven-Market Drug Forecast and Market Analysis - Product Thumbnail Image

Osteoporosis: Seven-Market Drug Forecast and Market Analysis

  • Report
  • June 2024
  • 105 Pages
  • Global
From
Chronic Kidney Disease: Seven-Market Drug Forecast and Market Analysis - Product Thumbnail Image

Chronic Kidney Disease: Seven-Market Drug Forecast and Market Analysis

  • Report
  • June 2024
  • 95 Pages
  • Global
From
Niemann Pick Type C: Opportunity Assessment and Forecast - Update - Product Thumbnail Image

Niemann Pick Type C: Opportunity Assessment and Forecast - Update

  • Report
  • June 2024
  • 54 Pages
  • Global
From
Dry Powder Inhaler Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update - Product Thumbnail Image

Dry Powder Inhaler Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

  • Report
  • May 2024
  • 128 Pages
  • Global
From
Attention Deficit Hyperactivity Disorder (ADHD): Opportunity Assessment and Forecast 2022-2032 - Product Thumbnail Image

Attention Deficit Hyperactivity Disorder (ADHD): Opportunity Assessment and Forecast 2022-2032

  • Report
  • May 2024
  • 75 Pages
  • Global
From
Amyotrophic Lateral Sclerosis: Opportunity Assessment and Forecast 2019-2029 - Update - Product Thumbnail Image

Amyotrophic Lateral Sclerosis: Opportunity Assessment and Forecast 2019-2029 - Update

  • Report
  • May 2024
  • 92 Pages
  • Global
From
Aortic and Vascular Graft Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update - Product Thumbnail Image

Aortic and Vascular Graft Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

  • Report
  • May 2024
  • 54 Pages
  • Global
From
Hyaluronic Acid Fillers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update - Product Thumbnail Image

Hyaluronic Acid Fillers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

  • Report
  • March 2024
  • 115 Pages
  • Global
From
Arthralgia (Joint Pain) - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Arthralgia (Joint Pain) - Global Clinical Trials Review, 2024

  • Clinical Trials
  • March 2024
  • 397 Pages
  • Global
From
Rare Disease ?Pipeline Analysis ?Landscape in 2023 - Product Thumbnail Image

Rare Disease ?Pipeline Analysis ?Landscape in 2023

  • Drug Pipelines
  • February 2024
  • 29 Pages
  • Global
From
Mucopolysaccharidosis II (Mps II) (Hunter Syndrome ) - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Mucopolysaccharidosis II (Mps II) (Hunter Syndrome ) - Global Clinical Trials Review, 2024

  • Clinical Trials
  • February 2024
  • 83 Pages
  • Global
From
Ankylosing Spondylitis (Bekhterev's Disease) - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Ankylosing Spondylitis (Bekhterev's Disease) - Global Clinical Trials Review, 2024

  • Clinical Trials
  • January 2024
  • 595 Pages
  • Global
From
Major Depressive Disorder: 68-Market Analysis and Sales Forecast - Product Thumbnail Image

Major Depressive Disorder: 68-Market Analysis and Sales Forecast

  • Report
  • January 2024
  • 17 Pages
  • Global
From
Major Depressive Disorder - Eight-Market Drug Forecast and Market Analysis - Update - Product Thumbnail Image

Major Depressive Disorder - Eight-Market Drug Forecast and Market Analysis - Update

  • Report
  • December 2023
  • 117 Pages
  • Global
From
Down Syndrome Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update - Product Thumbnail Image

Down Syndrome Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update

  • Report
  • November 2023
  • 100 Pages
  • Global
From
Acute Myeloid Leukemia (AML) Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032 - Product Thumbnail Image

Acute Myeloid Leukemia (AML) Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032

  • Report
  • September 2023
  • 79 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more